Author:
Tsikouras Panagiotis,Chalkidou Anna,Iatrakis Georgios,Oikonomou Efthimios,Bothou Anastasia,Kyriakou Dimitrios,Chatzi Ismail Mouchterem Aise,Alexiou Alexios,Nikolettos Konstantinos,Kritsotaki Nektaria,Nalbanti Theopi,Kotanidou Sonia,Zervoudis Stefanos,Nikolettos Nikolaos
Abstract
Menopause should be treated as a state of alteration of estrogen metabolism. It is characterized by a decrease in progesterone and an increase in estrogen followed by a drop in estrogen. The purpose of this study is to investigate the activity of hyaluronic acid 120 mg and isoflavones MF11RCE 80 mg, in the recovery of the symptoms of menopause and the treatment of its secondary complications such as osteoporosis, urogenital atrophy and accompanying urinary incontinence and vasomotor syndrome MF11RCE isoflavones are widely used to treat various disorders related mainly to women’s health and mainly osteoporosis and menopausal discomforts, based on epidemiological studies that brought the above diseases to a lower percentage, in populations with a high consumption of these plant estrogens. Isoflavones are derived from plants and structurally or functionally resemble endogenous-natural estrogens and their active metabolites. Therefore, they have significant estrogenic (agonistic/antagonistic) activity.